Insulin Degludec, a New Generation Ultra-Long Acting Insulin, Used Once Daily or 3-Times Weekly in People with Type 2 Diabetes: Comparison to Insulin Glargine

被引：0
|
作者：
Zinman, Bernard
Fulcher, Greg
Rao, Paturi V.
Thomas, Nihal
Endahl, Lars
Johansen, Thue
Lewin, Andrew
Rosenstock, Julio
Pinget, Michel
Mathieu, Chantal
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A11 / A11
页数：1
相关论文
共 50 条
  • [31] Insulin Degludec Is a New Generation Ultra-Long Acting Basal Insulin with a Unique Mechanism of Protraction Based on Multi-Hexamer Formation
    Jonassen, Ib
    Havelund, Svend
    Ribel, Ulla
    Hoeg-Jensen, Thomas
    Steensgaard, Dorte Bjerre
    Johansen, Thue
    Haahr, Hanne
    Nishimura, Erica
    Kurtzhals, Peter
    DIABETES, 2010, 59 : A11 - A11
  • [32] Flexibly timed once-daily dosing with degludec: a new ultra-long-acting basal insulin
    Josse, R. G.
    Woo, V.
    DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1077 - 1084
  • [33] Once-Weekly Insulin Icodec Versus Once-Daily Insulin Degludec in Insulin-Naive Chinese Participants with Type 2 Diabetes: A Post Hoc Analysis of ONWARDS 3
    Li, Yijun
    Kar, Soumitra
    Li, Congcong
    Liu, Ming
    Luan, Zijian
    Yuan, Guoyue
    Zhong, Xing
    Mu, Yiming
    DIABETES THERAPY, 2025, 16 (04) : 685 - 699
  • [34] Improved treatment satisfaction with once-weekly insulin icodec versus once-daily insulin degludec in basal insulin-treated type 2 diabetes (ONWARDS 2)
    Polonsky, W.
    Benamar, M.
    Carstensen, L.
    Davies, M.
    Donatsky, A. M.
    Franek, E.
    Kellerer, M.
    Goldenberg, R.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S400 - S400
  • [35] Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal-bolus therapy in type 1 and type 2 diabetes
    Kerlan, Veronique
    Gouet, Didier
    Marre, Michel
    Renard, Eric
    ANNALES D ENDOCRINOLOGIE, 2013, 74 (5-6) : 487 - 490
  • [36] Efficacy and safety of once-weekly insulin icodec versus once-daily insulin degludec in type 1 diabetes: ONWARDS 6
    Russell-Jones, D.
    Babazono, T.
    Cailleteau, R.
    Engberg, S.
    Irace, C.
    Kjaersgaard, M. I. S.
    Mathieu, C.
    Rosenstock, J.
    Woo, V.
    Klonoff, D. C.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S7 - S8
  • [37] Weekly Insulin May Be as Effective as Once Daily for Type 2 Diabetes
    Anderer, Samantha
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (17):
  • [38] Insulin Degludec Is a New Generation Ultra-Long Acting Basal Insulin Designed To Maintain Full Metabolic Effect While Minimizing Mitogenic Potential
    Nishimura, Erica
    Sorensen, Anders
    Hansen, Bo Falck
    Stidsen, Carsten
    Olsen, Grith Skytte
    Schaffer, Lauge
    Bonnesen, Christine
    Hegelund, Anne Charlotte
    Lundby, Anders
    Jonassen, Ib
    DIABETES, 2010, 59 : A375 - A375
  • [39] Comparison of Prandial AIR Inhaled Insulin Alone to Intensified Insulin Glargine Alone and to AIR Insulin Plus Intensified Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Once-Daily Insulin Glargine
    Rosenstock, Julio
    Eliaschewitz, Freddy G.
    Heilmann, Cory R.
    Muchmore, Douglas B.
    Hayes, Risa P.
    Belin, Ruth M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 : S63 - S73
  • [40] Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times
    Ashwell, SG
    Gebbie, J
    Home, PD
    DIABETIC MEDICINE, 2006, 23 (01) : 46 - 52
12345